✦ LIBER ✦

Three-year results of MIM salvage treatment for refractory/relapsed intermediate grade NHL

✍ Scribed by Giuseppe Abate; Salvatore Tafuto; Giampaolo Marcacci; Gaetano Corazzelli; Pietro Fimiani; Vincenzo Maria Monda; Enrico Gailli; Pasquale D'Andrea; Giancarla Iaccarino

Book ID: 114792006
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 192 KB
Volume: 54
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.1600-0609.1995.tb01627.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

MIM (mitoxantrone, ifosfamide, methotrex

MIM (mitoxantrone, ifosfamide, methotrexate) salvage chemotherapy for resistant/relapsed intermediate grade NHL

✍ Abate, G.; Tatuto, S.; De Rosa, V.; Marcaoci, G.; Monda, V.M.; Gailli, E.; Fimia 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 179 KB

Salvage treatment for children with refr

Salvage treatment for children with refractory first or second relapse of acute myeloid leukaemia with gemtuzumab ozogamicin: results of a phase II study

✍ Christian M. Zwaan; Dirk Reinhardt; Martin Zimmerman; Henrik Hasle; Jan Stary; B 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB

Long-term results of gemcitabine plus ox

Long-term results of gemcitabine plus oxaliplatin with and without rituximab as salvage treatment for transplant-ineligible patients with refractory/relapsing B-cell lymphoma

✍ Gaetano Corazzelli; Gaetana Capobianco; Manuela Arcamone; Pier Ferruccio Balleri 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 455 KB